Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/1999
12/21/1999US6004768 Crosslinked enzyme or antibody crystals may be used in an assay, diagnostic kit or biosensor for detecting an analyte, in an extracorporeal device for altering a component of a fluid
12/21/1999US6004761 Diagnosis and treatment of cancer including malignancies of the breast and lung
12/21/1999US6004756 Detecting the presence of mrna encoding a mammaglobin polypeptide in a sample from the patient
12/21/1999US6004753 Human S1-5 ECMP-like protein
12/21/1999US6004748 Inhibiting the transcription of a gene used to treat arthritis and cancer
12/21/1999US6004586 Contacting sperm with purified polypeptide having seqeunce defined in part by truncated portion of prosaposin molecule; contacting sperm with investments of one or more oocytes
12/21/1999US6004574 For administration of medically useful polypeptides, for administering polypeptides through inhalation
12/21/1999US6004557 Variants of human papillomavirus antigens
12/21/1999US6004556 Staphylococcus aureus RSBU-1
12/21/1999US6004555 Methods for the specific coagulation of vasculature
12/21/1999US6004554 Methods for targeting the vasculature of solid tumors
12/21/1999US6004553 Inhibitors of tumor necrosis factor receptor associated factor-(traf) mediated signal transduction; use in screening assays and as pharmaceuticals
12/21/1999US6004552 Administration of a monoclonal antibody capable of binding to a human cd40 antigen located on the surface of a human b cell, wherein the binding of the antibody to the cd40 antigen prevents the growth or differentiation of the b cell
12/21/1999US6004550 Intracellular expression of carboxypeptidase G2 in a nitrogen mustard prodrug system
12/21/1999US6004549 Crystalline protein controlled release compositions
12/21/1999US6004548 Polypeptides possessing primary structural conformation and biological properties of mammalian pluripotent granulocyte colony stimulating factor wherein at least one cysteine residue at positions 17,36,42,64,74 is replaced by alanine
12/21/1999US6004354 IceA gene and related methods
12/21/1999US6003516 Method for treatment of cancer and infectious disease
12/21/1999CA2197075C Method of gene therapy using dna vectors without selection marker gene
12/21/1999CA2150552C Antithrombotic
12/21/1999CA2147272C Convertible microemulsion formulations
12/21/1999CA2143510C Method for the isolation and purification of vitamin k-dependent proteins
12/21/1999CA2082951C Pulmonary administration of granulocyte colony stimulating factor
12/21/1999CA2072891C Pseudomonas exotoxin fusion proteins having carboxyl alterations with increased cytotoxicity
12/21/1999CA2065842C Process for inactivating viruses in blood and blood products
12/21/1999CA2065287C New hcv isolates
12/21/1999CA1340857C Synthetic plasmid transformant, feline interferon gene and method for producing feline interferon
12/21/1999CA1340855C Neurite-promoting factor and process for the manufacture thereof
12/21/1999CA1340853C Purification of recombinant interleukin-2
12/17/1999CA2235420A1 Antisense oligonucleotides for treating or preventing atopic diseases and neoplastic cell proliferation
12/16/1999WO1999064869A2 Back pain diagnosis and apparatus for use therein
12/16/1999WO1999064633A1 Herpes simplex virus origin binding protein n-terminal truncation (obp-nt)
12/16/1999WO1999064629A1 Acrp30r2, a homolog of acrp30 (30 kd adipocyte complement-related protein)
12/16/1999WO1999064615A1 Formulations for electroporation
12/16/1999WO1999064606A1 Tankyrase, a trfi binding protein
12/16/1999WO1999064604A2 Attenuated pestiviruses
12/16/1999WO1999064598A2 Novel insulin analogs with enhanced zinc binding
12/16/1999WO1999064597A1 β2 MICROGLOBULIN FUSION PROTEINS AND HIGH AFFINITY VARIANTS
12/16/1999WO1999064596A2 Proteins regulating gene expression
12/16/1999WO1999064595A1 THERAPEUTIC AND DIAGNOSTIC DOMAIN 1 β2GPI POLYPEPTIDES AND METHODS OF USING SAME
12/16/1999WO1999064594A2 Genes and gene expression products that are differentially regulated in prostate cancer
12/16/1999WO1999064593A2 Cell cycle regulation proteins
12/16/1999WO1999064591A1 Antibody against lar phosphatase subunit
12/16/1999WO1999064588A1 TGFβ RII RECEPTOR NUCLEIC SEQUENCE, CODED PEPTIDE, AND USES
12/16/1999WO1999064587A1 Polypeptides with beta-secretase type activity
12/16/1999WO1999064586A2 Phagocytic assay method
12/16/1999WO1999064585A2 Novel angiotensin receptor, production and use thereof
12/16/1999WO1999064584A2 Protein for regulating apoptosis
12/16/1999WO1999064577A1 Novel adenoviral vectors for gene therapy
12/16/1999WO1999064576A2 Human genes differentially expressed in colon cancer
12/16/1999WO1999064572A2 Poly(adp-ribose) polymerase gene
12/16/1999WO1999064464A2 Method for producing or enhancing a t-cell response against a target cell using a complex comprising an hla class i molecule and an attaching means
12/16/1999WO1999064463A1 Monoclonal antibodies specific for guanidino group-derived advanced glycosylation endproducts in biological samples
12/16/1999WO1999064461A2 Monoclonal antibodies, cross-reactive antibodies and method for producing the same
12/16/1999WO1999064457A1 Mammalian sperm protein pkdrej with homology to polycystin-1
12/16/1999WO1999064453A1 Purification process for production of mannan-binding lectin and an mbl medicinal product
12/16/1999WO1999064452A1 Gpr35a receptor
12/16/1999WO1999064450A2 Cif130 inhibits cell cycle progression
12/16/1999WO1999064448A2 Moraxella catarrhalis pilq proteins
12/16/1999WO1999064446A1 Pyrazinone protease inhibitors
12/16/1999WO1999064442A1 Peptide inhibitors of hepatitis c virus ns3 protease
12/16/1999WO1999064441A1 Method for preparing virus-safe pharmaceutical compositions
12/16/1999WO1999064436A1 Cloning and identification of the motilin receptor
12/16/1999WO1999064435A1 The human kidney specific gene kk86
12/16/1999WO1999064410A1 BENZO(b)THIEPINE-1,1-DIOXIDE DERIVATIVES, A METHOD FOR THE PRODUCTION THEREOF, MEDICAMENTS CONTAINING THESE COMPOUNDS, AND THEIR USE
12/16/1999WO1999064409A2 Benzothiepine-1,1-dioxide derivatives, method for producing them, medicaments containing these compounds and their use
12/16/1999WO1999064378A2 Directed combinatorial compound library and high throughput assays for screening same
12/16/1999WO1999064074A1 Methods and compositions for delivering proteins to macrophage cells and cells of macrophage derived lineage
12/16/1999WO1999064072A1 Conjugate consisting of a lectin and a blood coagulation factor
12/16/1999WO1999064070A1 Prevention and treatment of sepsis
12/16/1999WO1999064069A1 Antibodies to cytokines in the prevention and treatment of inflammatory bowel disease
12/16/1999WO1999064066A1 Immune tolerance-inducing agents containing hard keratin or keratin-like substance
12/16/1999WO1999064063A2 Collagenase application form
12/16/1999WO1999064062A1 New therapeutic use of pkb (proteine kinase b) enhancers
12/16/1999WO1999064061A1 GLUCAGON-LIKE PEPTIDE-1 IMPROVES β-CELL RESPONSE TO GLUCOSE IN SUBJECTS WITH IMPAIRED GLUCOSE TOLERANCE
12/16/1999WO1999064060A1 Pharmaceutical composition for the treatment of functional dyspepsia and/or irritable bowel syndrome and new use of substances therein
12/16/1999WO1999064059A2 Use of secretin for the treatment of autism and other neurological, behavioral and immunological disorders
12/16/1999WO1999064058A1 Skin preparations for external use
12/16/1999WO1999064057A1 Retinoic acid inducible dna sequences from lung cells
12/16/1999WO1999064056A1 Use of a cytokine regulatory agent to treat asthma
12/16/1999WO1999064055A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
12/16/1999WO1999064054A1 Multibinding inhibitors of topoisomerase
12/16/1999WO1999064053A1 β3-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064052A1 Novel leukotriene receptor antagonists and their uses
12/16/1999WO1999064051A1 Novel antibacterial compounds
12/16/1999WO1999064049A1 Novel antibacterial agents
12/16/1999WO1999064048A1 Inhibitors of hiv reverse transcriptase
12/16/1999WO1999064047A1 Novel antiviral compounds
12/16/1999WO1999064046A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5-ht3 receptors
12/16/1999WO1999064044A1 Novel therapeutic agents that modulate 5-ht receptors
12/16/1999WO1999064043A1 Muscarinic receptor antagonists
12/16/1999WO1999064042A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
12/16/1999WO1999064041A1 Multibinding agents that modulate nmda receptors
12/16/1999WO1999064040A1 Novel polyene macrolide compounds and uses
12/16/1999WO1999064039A1 Bradykinin antagonists
12/16/1999WO1999064038A1 Novel analgesic agents
12/16/1999WO1999064037A1 Novel therapeutic agents that modulate enzymatic processes
12/16/1999WO1999064035A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064034A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064033A1 Phosphodiesterase-v modulator drugs and their uses
1 ... 2442 2443 2444 2445 2446 2447 2448 2449 2450 2451 2452 2453 2454 2455 2456 2457 2458 2459 2460 2461 2462 ... 3163